Results · Apr-Jun 2026
Sudarshan Pharma Industries Q1 FY27 results
BlockbusterBlockbuster: sales up 20% or more & profit up 30% or more on the same quarter last year, with a wider operating margin.
Sales grew 20% to ₹174 crore from ₹145 crore in Apr-Jun 2025.
Operating profit grew 44% to ₹15.9 crore, an operating margin of 9.1% (up 1.5 points from a year ago).
Net profit grew 42% to ₹5.6 crore from ₹4 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales −21%, net profit −51%.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 174.4 | 145.3 | +20% |
| Operating profit (EBITDA) | 15.9 | 11.0 | +44% |
| Operating margin | 9.1% | 7.6% | +1.5 pts |
| Net profit | 5.6 | 4.0 | +42% |
Consolidated figures. Margins & ratios change in percentage points (pts).
The last 5 quarters
From the company's results filed on BSE (Consolidated). Business numbers only. Education & analysis, not investment advice or a recommendation.